Archive: November 2017

Elysium Health Aims to Improve People’s Lives through Innovative Science

MIT’s Leonard Guarante co-founded Elysium Health to give agency to consumers regarding their cellular health. Elysium Health is a company that focuses on proactive health. Founded in 2014, Elysium Health is a privately-held biotechnological firm. The organization works directly with the best clinicians, health practitioners, and scientists throughout the world in translating the latest technology and scientific breakthroughs into scientifically potent and effective health products that elicit their actions at the cellular level.

Elysium Health dedicates itself to the identification and development of the most promising and innovative natural ingredients into an effective dietary supplement. Elysium Health envisions longer and healthier lives through the application of extraordinary science. The company’s mission is to provide solutions to the most complex challenges in the health sector through the use of science and technology.

Elysium Health employs a unique approach to achieving their mission. Elysium’s model develops compelling health products from nature to assist their clients in promoting their health in a proactive approach.

Elysium’s supply chain involves multiple quality checks before shipping their products to the consumers. For instance, during the manufacture of Basis, their premier supplement, a total of five purity and quality checks form the foundation of quality control before shipping the product. All of their manufacturing plants are within the United States. The facilities are compliant with the FDA regulations. Therefore, the company releases products of desired purity and quality for human consumption.

Elysium’s scientific advisory group comprises of leaders in technology and science who advocate for better and innovative approaches to health. The highly experienced board members guide the scientific way of the company. The network of scientists and health professionals that are on this board provide practical advice and guidance on the identification and development of products, ongoing studies, and clinical trials. The team uses scientific literature on proactive health to advise on research and clinical trials, as well as maintaining the integrity of the products. The group also actively participates in areas such as aging, biochemistry, and neuroscience to provide Elysium Health with the intellectual resources to build clinically validated products. Furthermore, collaboration with other top-achieving institutions helps them achieve partnerships in clinical studies.

Basis is the first product marketed by Elysium Health. It consists of a clinically-validated combination of two key components that help support cellular well-being. Nicotinamide riboside in the Basis acts as the precursor of NAD+. NAD+ is the coenzyme involved in many metabolic functions within the body.

Waiakea Water to Switch to a Fully Degradable Bottle in 2018

Hawaiian premium drinking water company, Waiakea Hawaiian Volcanic Water, announced in September 2017 that it would be switching to a 100 percent recyclable plastic and fully degradable bottle in 2018. The move is a significant step aimed at enhancing sustainability, which the company is keen at.

The switch will see the company as the first to apply nano-additive technology. They will intervene in the plastic waste management process by chemically weakening the bottles during the manufacturing procedure. The technique accelerates the natural degradation process as it turns the plastic into a degradable carbon-based wax.

According to Ryan Emmons, the founder and chief executive officer of Waiakea, the achievement comes after years of experimenting. The company now has a patent on the degradation of plastic from the United States.

Presently, Waiakea Volcanic Water uses recycled polyethylene terephthalate, a material that uses less energy to make, to offset the concerns of using plastic bottles. Additional efforts that the company engages in to allow sustainability include practices in their water production efforts aimed at minimizing emissions and lowering the carbon footprint

Their efforts in reducing carbon emissions have seen the company certified CarbonNeutral, a certification given by Natural Capital Partners. It awards enterprises that implement renewable energy practices and reduce emissions.

Waiakea Hawaiian Volcanic Water was founded in 2012 by Ryan Emmons. Access to the volcanic water when he spent time there gave him the inspiration he needed to start a bottled water company that employs unique and sustainable processes.

Their volcanic water goes through a natural filtration process that goes through the most active volcano in the world, Mauna Loa. The mountain peak is located in a remote area away from possible pollution and unnatural additives. As a result, there is a guarantee of the water’s purity.

Before getting to the Waiakea aquifers, it passes through volcanic rocks that enrich it with minerals, calcium, potassium, and electrolytes. It also undergoes purification that removes acid, making it naturally alkaline. These qualities are beneficial to the body which places Waiakea Water among the best brands you can have anywhere in the world.

How Louis Chenevert Left a Legacy at UTC

Louis Chenevert’s time at United Technologies Corporation (UTC) as the chief executive officer was one that was marked by phenomenal success. He established high standards that exceeded what other CEOs could do. One of his largest successes was the acquisition of Goodrich, which, amounting to an 18.4 billion deal, was one that built a huge synergy within the company and what they could supply in-house to their clients.

When Airbus chose Pratt & Whitney, one of UTC’s subsidiaries, for their new engine supplier it was largely due to the efforts of Louis Chenevert. He had pushed for development of new materials which would allow the engine to burn hotter and thus more efficiently. One of the other concepts of this engine that has had longlasting impact is that it decoupled the fan. This change has paid off since as Pratt & Whitney builds even more advanced and larger engines using this technology.

It was at Pratt & Whitney Canada that Louis Chenevert had first joined UTC in 1993. In 1999 he was named as the companies president and in 2006 he was elected as chairman of the board of UTC. He was eventually named CEO and served in this position until he decided to leave UTC on December 8, 2014. After taking some time off he joined Goldman Sachs where he was an advisor in their Merchant Banking Division.

Louis Chenevert is from Canada. He attended HEC Montreal and earned a bachelor’s degree in production management. After earning his degree he found a job at General Motors where he stayed, rising to higher levels of responsibility, for 14 years. Once he started his career at Pratt & Whitney he quickly familiarized himself with their production management policies and how to grow both sides of their business which includes both civil and military aviation.

Over the course of his professional career, Louis Chenevert has been honored several times. He was presented with an honorary doctorate by HEC Montreal, his alma mater, in 2011. It was also in this same year that he was named by Aviation Week & Space Technology as their Person of the Year.

Transparency Is Inherent At Securus Technologies

There is a lot happening at Securus Technologies. But the best thing is that they are completely transparent about it. In fact, they have given an open invitation to their present clients as well as prospective customers about the products they make and their specific features.

 

This is because Securus Technologies is well aware that people will buy their products only once they know more about them as well as the benefits being provided by them. In this regard, anyone can go and visit their facility and ask for a guided tour.

 

This is the unique thing about this company. I do not know of any other company except Securus Technologies that is providing such an option to its clients. This also indicates how much confidence Securus Technologies has in its products.

 

Besides, Securus Technologies is always trying to improve its products. In order to do this, the company is always asking for feedback from its clients. It wants to know how their products are providing safety to the Facilities.

 

Also, Securus Technologies wants to know about the additional features that the clients will like to get incorporated into these products. This is because innovation is the only option for survival. Since technology is moving at a fast pace, so is the world of criminals.

 

This means that everyone, including Securus Technologies, has to keep pace. In fact, security is a part of the DNA of everyone at Securus Technologies. All of them are very keen to enhance security in the prisons.

 

The jail authorities are also keen to solve any previous cases. In this regard, they require the help of criminals. This is not forthcoming. But they can record the conversations between inmates through the help of Securus Technologies. This has helped them many times before in resolving the unsolved cases.

 

 

The success of IDLife Under the Leadership of Logan Stout

IDLife is a health and wellness company which was founded by Logan Stout. Logan Stout is an accomplished entrepreneur, a philanthropist, and best-selling author. He is one of the most sought-after keynote speakers due to his distinguished track record of leadership, team-building, and success principles. IDLife has grown and developed since its foundation and has partnered with celebrity trainer Jen Widerstorm, Troy Aikman and the billionaire Darwin Deason and many others. The company recently ventured into health and wellness and has taken an initiative to educate the general public on the importance of health and wellness through partnering with internationally recognized health authors and fitness ambassadors to provide the best quality of nutrition products. IDLife was ranked amongst the top 100 Solid Top MLM Companies worldwide.

Logan Stout has undertaken many philanthropic activities due to his passion for helping others. In order to empower and inspire people, he authored the book Stout Advice; Secrets to Building yourself, people, and teams. The book was published in 2013, and it was recommended by successful entrepreneurs such as Daymond John and Barbara Corcoran from ABC’s Sharks Tank. Logan is the founder and CEO of Dallas Patriots Baseball Organization which is now one of the largest worldwide. Through this team, he mentors and leads youths, therefore, giving them an opportunity to play college baseball. Logan together with his wife Hayley are patrons and chairs of several charitable organizations such as American Heart Association, the Boys and Girls Club of Collin County and they founded the Youth Athletes Foundation.

On the 30th of August, after the Hurricane Harvey hit Texas, Logan Stout woke up at 4 o’clock in the morning, closed all his offices and went to help the hurricane victims. He gathered all the supplies that were required for the cleanup activities. He turned his offices into storage for pellets which were later taken to the cities of Houston and Tomball. He gave his warehouse out for any purpose it would be needed for by the victims, and then he took his trucks and filled them with boats and supplies for transportation to any required destination in order to assure safety and survival for everyone affected by the hurricane. He was joined by other entrepreneurs in the area. He believes that it is imperative to do something good for someone who is in need as it is a special gift and it makes people feel loved.

Learn More: www.facebook.com/IDLifeCorporate/

Jason Hope: Aging in a Better Way

As age progresses, metabolic processes adversely affect the molecular and cellular structures of the body. Current medicine is aimed towards crisis management thus diminishing the quality of life at old age, which is possible with rejuvenation of biotechnology. This is a therapy that targets the damaged tissues to remove, repair or replace. With this approach to the anti-aging question, the world can redefine aging, live lives full of vigor and free health from the gravitational pull of time. SENS Foundation has dedicated significant efforts towards this cause. Some of the most notable contributors are Peter Thiel of Paypal and Jason Hope, entrepreneur and Internet of Things enthusiast. The foundation is not looking to make people live forever. They just want to find ways for humans to have negligible senescence. This is the absence of the symptoms of aging.

 

Offering Full Support

In 2010, Jason Hope donated $500,000 to the SENS Foundation. This money was geared towards building and equipping the Cambridge SENS Laboratory. The money also went a long way to implement new research into the break down of advanced glycation end products in human tissue. In simpler terms, they are known as AGE-Breakers or AGEs. They are responsible for the degradation of skin among other symptoms of aging. Jason Hope believes in the work the foundation is doing and has donated a further $1 Million for the cause. Jason finds the approach the SENS Foundation is taking fresh as it is finding ways to prevent age related diseases rather than waiting to manage them. His commitment to the entire initiative is to die for. He will not rest until the quality of human life is established, and his Linkedin.

An Eye on the Future

Jason Hope has built a reputation for his predictions in technology from studying market analytics. He holds a degree in Finance from the Arizona State University. He also holds an MBA from W. P. Carey School of Business at Arizona State University. After college, Jason Hope started a mobile communications company. Today he mentors high school students in Scottsdale, Arizona and develops grants for entrepreneurs. He is an Internet of Things enthusiast. Jason primarily oversees his businesses and projects from Scottsdale where he resides. He has an interest in politics as it pertains to business. Jason Hope is a well sought after advisor on business, finance and technology, not to mention that he is also a passionate philanthropist, and more information click here.

The Factors Behind the Growth Being Experienced By Oncotarget

Oncotarget is a known publication institution that has been making its published journals public through its website. Oncotarget disseminates these publications to its audience for free on its online platform. Most of Oncotargets audience and avid readers comprise of various professionals in diverse fields in science.

Individuals who wish to be granted unlimited access to Oncotargets materials have to subscribe as members. However, it’s worth noting that subscribing as a member is free of charge and no credit card information Is required from you by Oncotarget. The only requirements professionals who want unlimited access to Oncotargets publications need to provide is an email address they will be using to get alerts and the company’s newsletters.

Oncotarget makes its journal publications on a weekly basis. Every week they post two new journals on their website. Initially, Oncotarget published one journal on a weekly basis which they made available to their readers through its website. That has long changed since the company has been experiencing a surge of new subscribers on its platform.

The additional individuals have increased the demand for the publications which has, in turn, led to the company raising the number of journals posted online from one to two, every week. When it comes to the strategy used to choose the publication the company makes, a lot of focus is placed on the demand and trending scientific issues. Oncotarget prides itself as a multi-discipline publication company; this explains why the journals posted extensively cover topics from different fields.

Oncotarget has given significant effort on ensuring that the materials they post to their website have a considerable appeal and reach the maximum potential impact on their readers. They have been achieving this by creating quality publications and journals that address issues that are of grave concern. The company has also dedicated its efforts to publishing insightful content that expounds on the ongoing challenges faced by the scientific world.

Just like modern publication companies, Oncotarget has recently been investing in the adoption of a robust, fast and sophisticated indexing algorithm. The reason behind this is to improve the speeds at which information is obtained and shared on their website.

The American Institute of Architects Celebrates 160 Years of Excellence

     In 2017, the American Institute of Architects celebrated its 160th birthday. The industry and the institution that represents it have come a long ways over that time span. But the basic principles on which the founders based the organization have proven to be timeless. In the United States, the public’s confidence in the built environment is, perhaps, as high as its ever been. The fact that so few catastrophes relating to the quality of buildings and their design happen in a country so vast is testament to the extreme efficacy with which the American Institute of Architects has executed its mission.

The AIA today

Today, the American Institute of Architects is the de facto model for all such organizations across the globe. It serves as a standard bearer and as a model of ethical uprightness, showing the world what is possible with high standards and ethics. The institution has maintained the rigor and professionalism of the American architectural industry at a level that has been unsurpassed throughout the history of its existence.

All of this has resulted in America becoming the soil upon which the most important architectural schools of the last 150 years have planted their seed and grown to fruition. Even schools that did not originate in the United States, such as Neoclassicism, Beaux Arts and Art Deco, have found their wings in cities across the United States, particularly in the high grandeur of the skyscrapers in cities like Detroit, New York and Chicago. Other schools of architecture, such as the Victorian and Italianate styles that were so popular with wealthy home owners throughout the second half of the 19th century, can almost be fully credited as uniquely American creations, at least in their specific implementations. All of this was made possible by having a strong professional organization that instilled confidence in the public and ensured that the country’s top talent was both recognized and promoted.

The American Institute of Architects is, today, run by renowned architect, scholar and biographer Robert Ivy. During his tenure, the organization has continued to expand, today counting over 90,000 members in its ranks. The institution bequeaths fellowships and awards, with the position of Fellow and the AIA Gold Medal respectively being its highest honors. All of the most brilliant luminaries of American architecture have been high ranking members in the institution, including such names as Frank Lloyed Wright, Daniel Burnham and William LeBaron Jenney

Sahm Adrangi: From Wall Street to Retired at 35

Sahm Adrangi is best known for publishing research and his successful short selling, but he is also the Founder and Chief Investment Officer of Kerrisdale Capital Management, having been involved in all aspects of the firm since it was founded in 2009. He has managed the firm to a valuation of $150 million as of July 2017, after beginning it with under $1 million.

Adrangi believes in considering under-followed long sales along with overhyped shorts, and has seen his success occur by understanding aspects of the market others overlook. Kerrisdale researches these misconceptions that affect companies’ most fundamental business workings, and share their research on the company website, Twitter feed, and on third party websites.

In an investment conversation with a journalist, Adrangi discussed his beliefs and his success. He cited his firmly held belief in keeping some secrets, such as the company through which Kerrisdale raised $100 million. While other stockbrokers often will hedge their bets on a certain industry foresee changing quickly, Kerrisdale and Adrangi are working silently behind the scenes to make things happen, and plan to reveal their secrets at a later date.

He teases hints, though, telling that the company involved is worth over $10 billion, and he knows that what he’s done has struck a chord within what he calls the “alternative community.”

Adrangi discusses the companies that Kerrisdale has essentially bet against in the past – including satellite company Globalstar, drug maker Zafgen, and pharmaceutical company Sage Therapeutics – and happily promotes that his company is sitting on north of $500 million themselves because of these groundbreaking sales he has led.

The businessman himself is a Canadian but was born in Iran, and his global viewpoint gives him a unique insight to the world of trade. He describes himself as generally subdued, but get him riled up and the passion spills out. He speaks one line about stock strategy, and his timeliness might speak for his general outlook on business: “Maybe it’s time for us to go nuts.” And gone nuts he has – to the tune of hundreds of millions.

Read More: www.crunchbase.com/person/sahm-adrangi

Mikhail Blagosklonny Article

Mikhail Blagosklonny Scientific Researcher–Professor and Proponent of a Cancer-Free Society.Mikhail Blagosklonny is a scientist studying cancer and aging who formulated a hypothesis involving both with TOR signaling. He has had a distinguished as a scientist, professor, writer and editor-in-chief with a focus on cancer treatments, cures and anti-aging in the prevention of aging illness and disease. Mr. Blagosklonny believes that one day people can be cancer free and has focused his research and teaching in this direction.

Writing and Publications

Mr. Blangsklonny is top in his field of study and as a professor that has made one of his goals to bring awareness to the medical community during his career. He has written numerous publications in his field of science, cancer, and aging. Dr. Blangslonny currently has about 270 peers reviewed publications with over 25,000 citations that have brought awareness to his medical and scientific research findings. One of the other things Mikhail Blagosklonny known for is his seat as editor-in-chief of the Onctarget, Cell Cycle, and other publications.

Education and Degrees

Mr. Mikhail Blagosklonny attended college in Russia earning his medical degrees at the University of St. Petersburg, Russia. Mikhail Blagosklonny earned an M.D. degree in internal medicine. He then went on to earn a Ph.D. in experimental medicine and cardiology at the same University.

Employment Positions

Mikhail Blagosklonny has taken positions in both the teaching and scientific settings. He took a position at the New York Medical College in Valhalla, New York in 2002. At this college the position Mr. Blagosklonny held was an associate professor of medicine. In another position the doctor worked in a position with the title of senior scientist. This position was held at Ordway Research Institute, Albany New York. Afterward in 2009 he went to work for Roswell Park Cancer Institute. He was appointed to hold the title professor of oncology at the Roswell Institute.

Scientific Research

Through his scientific research that was focused on cancer and aging he believes rapamycin is important. The drug is an anti-cancer drug with properties that also helps with anti-aging and it showed proof it could slow tumor growth. He considers rapamycin to be a drug that could extend life. As another focus of his scientific research, he studied the mechanisms of aging, which helped show how this drug may be beneficial. After taking the position at Roswell Park Cancer Institute he claimed he would be teaching the new generation of future cancer researchers. However what he studied in his position as a scientist helped to develop cancer drugs and non-genotoxic compounds to suppress aging diseases.During his career in teaching positions, writing and scientific research it has included molecular biology, cellular biology, cell cycle, anti-cancer therapeutics, tumor suppressors and clinical investigations. In this research, Mr. Blagosklonny formed the hypothesis that shows a potential connection with TOR signaling. This signaling is within aging and cancer along with the use of anti-cancer drugs like rapamycin.